{
  "trial_id": "NCT04537923",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, duration of type 2 diabetes, baseline HbA1c, body mass index (BMI), weight, fasting plasma glucose, use of metformin, use of sulfonylureas, use of dipeptidyl peptidase 4 inhibitors, estimated glomerular filtration rate (eGFR), history of cardiovascular disease, history of pancreatitis, history of diabetic retinopathy, gastrointestinal motility disorders, history of thyroid carcinoma, use of weight loss drugs.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Hemoglobin A1c",
          "baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "duration of type 2 diabetes",
        "body mass index (BMI)",
        "weight",
        "fasting plasma glucose",
        "use of metformin",
        "use of sulfonylureas",
        "use of dipeptidyl peptidase 4 inhibitors",
        "estimated glomerular filtration rate (eGFR)",
        "history of cardiovascular disease",
        "history of pancreatitis",
        "history of diabetic retinopathy",
        "gastrointestinal motility disorders",
        "history of thyroid carcinoma",
        "use of weight loss drugs"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline HbA1c, Body Mass Index, Duration of Diabetes, Daily Insulin Dose, Use of Metformin, Systolic Blood Pressure, Diastolic Blood Pressure, Estimated Glomerular Filtration Rate (eGFR),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Hemoglobin A1c",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Body Mass Index",
        "Duration of Diabetes",
        "Daily Insulin Dose",
        "Use of Metformin",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Estimated Glomerular Filtration Rate (eGFR)"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Diagnosis Duration, HbA1c, BMI, Insulin Dose, Metformin Use, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, Triglycerides, eGFR, Diabetic Retinopathy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Hemoglobin A1c",
          "HbA1c"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Diabetes Diagnosis Duration",
        "BMI",
        "Insulin Dose",
        "Metformin Use",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Total Cholesterol",
        "Triglycerides",
        "eGFR",
        "Diabetic Retinopathy"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, HbA1c, fasting plasma glucose, insulin glargine dose, metformin dose, sulfonylureas dose, dipeptidyl peptidase 4 inhibitors dose, estimated glomerular filtration rate, history of cardiovascular disease, history of pancreatitis, history of thyroid disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Hemoglobin A1c",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of type 2 diabetes",
        "fasting plasma glucose",
        "insulin glargine dose",
        "metformin dose",
        "sulfonylureas dose",
        "dipeptidyl peptidase 4 inhibitors dose",
        "estimated glomerular filtration rate",
        "history of cardiovascular disease",
        "history of pancreatitis",
        "history of thyroid disease."
      ]
    }
  }
}